Australia Spinal Muscular Atrophy (SMA) Market Analysis

$3,500.00$7,500.00

  • Type: Rare Disease Area
  • Published : April 2021
  • Region: APAC
  • Country: Australia
  • Report ID : 4113

  • Format: PPT, PDF

Australian Spinal Muscular Atrophy Therapeutics Market: Segmented by Disease Type, Diagnosis, Therapeutics, and Distribution Channel – Size, Share, Impact, Growth, Trends, and Forecasts (2020 – 2028F)

Clear
SKU: 4113 Categories: ,

Report Overview

The Australian Spinal Muscular Atrophy Therapeutics Market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

The Spinal Muscular Atrophy (SMA) is a group of genetic neuromuscular disorders that affect the nerve cells that control voluntary muscles (motor neurons). The loss of motor neurons causes progressive muscle weakness and loss of movement due to muscle wasting (atrophy). The severity of the symptoms, the age at which symptoms, begin, and genetic cause varies by type. Many types of SMA mainly affect the muscles involved in walking, sitting, arm movement, and head control. Breathing and swallowing may also become difficult as the disease progresses in many types of SMA. In some types of SMA, the loss of motor neurons makes it hard to control movement of the hands and feet.

SMA type 1, 2, 3, and 4 are caused by changes (or pathogenic mutations) in the SMN1 gene and are inherited in an autosomal recessive manner. The disease generally manifests early in life and is the leading genetic cause of death in infants and toddlers. SMA is caused by defects in the Survival Motor Neuron 1 (SMN1) gene that encodes the SMN protein. The SMN protein is critical to the health and survival of the nerve cells in the spinal cord responsible for muscle contraction (motor neurons).

SMA is one of the most common rare disease. Approximately one in 6,000 babies born have SMA, and about one in 40 people carry a copy of the altered gene that causes the condition (although they do not have the condition themselves).

Market Growth Drivers

The overall burden of Spinal Muscular Atrophy is one of the highest in terms of cost and healthcare services in the rare disorder. The rising incidence of Spinal Muscular Atrophy due to the increasing population is one of the key factors for the growth in SMA treatment market. This growth is attributed to the rapidly developing health infrastructure in the Australia, the initiatives undertaken by various public, as well as non-profit, organizations for creating awareness regarding SMA have increased remarkably which is propelling the demand for efficient therapeutic options leading to better patient outcomes.

Increase in R&D investment by major companies will boost the market growth in the forecast period. Granting of various drug designation to novel drugs is also accelerating the market growth for spinal muscular atrophy treatment. In recent times, there have been few substantial and very significant product launches in gene therapy for the treatment of spinal muscular atrophy disease.

Market Restraints

However, the high cost of treatment for Spinal Muscular Atrophy is hindering the market growth. Additionally, lack of experienced professionals and less adoption rate of Spinal Muscular Atrophy treatment options are also restraining the market growth.

1. Australian Spinal Muscular Atrophy Therapeutics Market Overview………………………………………………………………………………………………………………………………..
A. Market Size
2. Market Growth Drivers and Restraints……………………………………….………………….
Market Growth Drivers
A. Increase in R&D Investment & Introduction of Novel Therapies
B. Developing Healthcare Infrastructure & Rise in Awareness
Market Restraints
A. Higher Cost of Treatment
B. Lack of Experienced Professionals
3. Major Types of Spinal Muscular Atrophy………………………………………………………………..
A. SMA with Progressive Myoclonic Epilepsy (SMA-PME)
B. SMA with Respiratory Distress 1 (SMARD1)
C. Adult-onset Spinal Muscular Atrophy
D. X-linked Infantile Spinal Muscular Atrophy
4. Spinal Muscular Atrophy Therapeutics Market Segmentation…………………..
A. By Disease Type
I. Type 1 SMA
II. Type 2 SMA
III. Type 3 SMA
B. Diagnosis
I. Physical Examination
II. Electromyography
III. Muscle Biopsy
IV. Genetic Counselling
V. Chorionic Villus Sampling Test (CVST)
C. By Therapeutics
I. Evrysdi (risdiplam)
II. Spinraza (nusinersen)
III. Zolgensma (onasemnogene abeparvovec)
IV. Physical Therapy
V. Chest Physiotherapy
D. By Distribution Channels
I. Hospital Pharmacies
II. Retail Pharmacies
III. Online Pharmacies
5. Spinal Muscular Atrophy Major Drugs Market Share………………………………
A. Market Analysis, Insights and Forecast – By Revenue Type
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles………………………………………………………………….
A. Novartis Company overview, Product & Services, Strategies & Financials
B. Biogen Company overview, Product & Services, Strategies & Financials
C. Roche Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape……………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth…………………………………………………………
A. New Trends and Development of Spinal Muscular Atrophy Therapeutics Market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Disease Type:

On the basis of disease type, the Spinal Muscular Atrophy Therapeutics market has been segmented into

  • Type 1 SMA
  • Type 2 SMA
  • Type 3 SMA
  • Type 4 SMA

Type 1 SMA generated the highest revenue amongst all the categories in 2020. Thus, type 1 SMA is anticipated to remain the most dominant in terms of revenue as the majority of the cases of the disorder are of this type, which has led to it dominating in terms of market share. Increasing awareness of the Type 2 SMA and increasing adoption of treatment is also anticipated to drive the growth of this type over the forecast period.

By Diagnosis:

On the basis of diagnosis, the Spinal Muscular Atrophy Therapeutics market can be classified into

  • Physical examination
  • Electromyography
  • Muscle Biopsy
  • Genetic Counselling
  • Chorionic villus sampling (CVS)
  • Amniocentesis
  • Genetic Blood Test
  • Others

A physical examination may be done to look for signs of SMA or similar conditions. Electromyography and muscle biopsy have also been used. Genetic counselling helps you to understand that if you’re at risk of having a child with SMA. While chorionic villus sampling (CVS), and Amniocentesis are usually carrying out during pregnancy. If the child has typical symptoms of SMA, a genetic blood test can be done to confirm the condition.

By Therapeutics:

Based on the therapeutics, the Spinal Muscular Atrophy Therapeutics market can be segmented into

  • Evrysdi (risdiplam)
  • Spinraza (nusinersen)
  • Zolgensma (onasemnogene abeparvovec)
  • Physical Therapy
  • Chest Physiotherapy
  • Nutritional therapy
  • Use of Ventilators

Nusinersen has been accounted for maximum share in 2020, which is attributable to the fact that Nusinersen is the most effective drug among others in the market. However, Zolgensma (Onasemnogene Abeparvovec) which got approved later after Spinraza, however expected to witness growth in the coming years owing to the rising incidence of spinal muscular atrophy disease and the greater patient adoption rate.

By Distribution Channels:

In terms of distribution channel, the Spinal Muscular Atrophy Therapeutics market can be categorized into

  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies

In terms of value, the hospital pharmacies accounted for the leading market share in 2020, which is attributable to the fact that the majority of the medications for Spinal Muscular Atrophy Treatment can be only administered intravenously and can so only be done by trained medical professionals. Hence, the hospital pharmacies segment is anticipated to enhance the market share over the forecast period.

Top Major Players

The Australian Spinal Muscular Atrophy Therapeutics market is a highly competitive market and major key players are adopting strategies; organic as well as inorganic market strategies. Evrysdi is the only oral approved drug while other prominent drugs administered by parenteral route and thus possess better efficacy. The prominent key players prevailing in the Australian market are Biogen Australia Pty Ltd, Novartis Pharmaceuticals Australia Pty Ltd, Ionis Pharmaceuticals, and Roche Products Pty Ltd. among others.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements